| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |